those assay results seem more a risk than something to look forward to. If they're good it's just business as planned. Nothing to see here really. Not sure how this is price sensitive?
IRI Tech smallcap Integrated Research finds new CEO in Ian Lowe. Can the stock return to its lockdown highs?